1) indapamide SR
吲哒帕胺缓释剂
1.
A randomised,double-blind,multicenter,parallel control clinical study of perindopril /indapamide combination vs. indapamide SR in patients with hypertension;
目的:比较低剂量培哚普利／吲哒帕胺复合制剂与吲哒帕胺缓释剂治疗高血压患者血压的变化和治疗反应率及其安全性。
2) indapamide sustained release
吲哒帕胺缓释片
1.
Evaluation of irbsartan and indapamide sustained release by different methods of trough/peak ratio and smoothness index calculated in the treatment of hypertention;
不同方法计算谷峰比值和平滑指数评价伊贝沙坦和吲哒帕胺缓释片的降压疗效
3) indapamide
吲哒帕胺
1.
Effects of the Combination therapy with Indapamide and Irbesartan on Hepertension and reversion of Ventricuiar Remodeling;
伊贝沙坦联合吲哒帕胺对原发性高血压的疗效及左室肥厚的逆转作用
2.
Influence of indapamide on circadian rhythm in patients with essential hypertension;
吲哒帕胺对原发性高血压患者血压昼夜节律的影响
3.
Clinical Observation of Indapamide in Treatment of Senile Hypertension;
吲哒帕胺治疗老年高血压临床观察
4) indapamide extentab
吲达帕胺缓释片
1.
Effect of valsartan combined with indapamide extentab on left ventricular hypertrophy and diastolic function defect of the heart in type 2 diabetes patient with hypertension;
缬沙坦联用吲达帕胺缓释片对2型糖尿病伴高血压左心室肥厚及舒张功能的影响
5) Indapamide Tablets
吲哒帕胺片
6) combination of perindopril andindapamide
培哚普利/吲哒帕胺复合制剂
补充资料：吲满胺
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条